Literature DB >> 2994149

Effects of opiate antagonists and putative kappa agonists on unpunished and punished operant behavior in the rat.

S E DeRossett, S G Holtzman.   

Abstract

The effects of naloxone and diprenorphine, opiate antagonists with different receptor-binding properties, and the putative kappa-receptor agonists, ketocyclazocine and ethylketocyclazocine (EKC), were studied on food-reinforced responding in rats. Behavior was maintained under a multiple-component 1-min variable-interval schedule in which 12-min periods of unpunished responding alternated with 4-min periods in which each response was punished by a brief electric footshock. Daily sessions were 1 h. Naloxone (0.01-10 mg/kg) decreased unpunished responding only slightly; punished responding was decreased significantly to 66% of control by 10 mg/kg. Diprenorphine (0.01-10 mg/kg) did not affect unpunished responding and increased punished responding dose-dependently to as much as 190% of control. EKC (0.01-1.0 mg/kg) decreased unpunished and punished responding dose-dependently and comparably, whereas ketocyclazocine (0.01-1.0 mg/kg) decreased unpunished responding but did not significantly affect punished responding. Diprenorphine was more potent than naloxone in blocking the decreases in responding produced by the kappa agonists. Differences in the behavioral effects of naloxone and diprenorphine appear to reflect the different receptor-binding properties of the two opiate antagonists.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994149     DOI: 10.1007/bf00427896

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

1.  Multiple opiate receptors. Enkephalins and morphine bind to receptors of different specificity.

Authors:  K J Chang; P Cuatrecasas
Journal:  J Biol Chem       Date:  1979-04-25       Impact factor: 5.157

2.  Interactions between narcotic agonists, partial agonists and antagonists evaluated by schedule-controlled behavior.

Authors:  R A Harris
Journal:  J Pharmacol Exp Ther       Date:  1980-06       Impact factor: 4.030

3.  Effects of naloxone, diprenorphine, buprenorphine and etorphine on unpunished and punished food-reinforced responding in the squirrel monkey.

Authors:  S E DeRossett; S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1984-03       Impact factor: 4.030

4.  Effects of naloxone and diprenorphine on spontaneous activity in rats and mice.

Authors:  S E DeRossett; S G Holtzman
Journal:  Pharmacol Biochem Behav       Date:  1982-08       Impact factor: 3.533

5.  Behavioral effects of buprenorphine and diprenorphine under a multiple schedule of food presentation in squirrel monkeys.

Authors:  L A Dykstra
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

6.  The effects of naloxone, diprenorphine, and diazepam on responding suppressed by pre-shock and pre-food stimuli.

Authors:  J M White; S G Holtzman
Journal:  Life Sci       Date:  1983-01-31       Impact factor: 5.037

7.  [3H]diprenorphine receptor binding in vivo and in vitro.

Authors:  W Sadée; D C Perry; J S Rosenbaum; A Herz
Journal:  Eur J Pharmacol       Date:  1982-07-16       Impact factor: 4.432

8.  Interactions between narcotic agonists, partial agonists andd antagonists evaluated by punished an unpunished behavior in the rat.

Authors:  D Snell; R A Harris
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

9.  Naloxone and shock-elicited freezing in the rat.

Authors:  M S Fanselow; R C Bolles
Journal:  J Comp Physiol Psychol       Date:  1979-08

10.  Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain.

Authors:  H W Kosterlitz; S J Paterson; L E Robson
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

View more
  1 in total

1.  Effects of d-amphetamine, morphine, naloxone, and drug combinations on visual discrimination in rats.

Authors:  J S Andrews; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.